Eric Warren

Insider Reports History

Entity
Individual
Location
3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Warren:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Chief Commercial Officer Common Stock 370K $551K $1.49 Mar 18, 2025 Direct
Esperion Therapeutics, Inc. Chief Commercial Officer Stock Option (right to buy) 191K $309K $1.62 Mar 14, 2025 Direct

Insider Reports Filed by Eric Warren

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. Mar 18, 2025 1 -$3.62K 4 Mar 19, 2025 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2025 2 $0 4 Mar 17, 2025 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Feb 19, 2025 1 -$446 4 Feb 20, 2025 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jan 17, 2025 1 -$278 4 Jan 21, 2025 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Dec 17, 2024 1 -$5.43K 4 Dec 18, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Nov 19, 2024 1 -$427 4 Nov 20, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Oct 17, 2024 1 -$227 4 Oct 18, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Sep 17, 2024 1 -$4.65K 4 Sep 18, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Aug 19, 2024 1 -$411 4 Aug 20, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jul 17, 2024 1 -$279 4 Jul 19, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jun 18, 2024 1 -$7.25K 4 Jun 20, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. May 17, 2024 1 -$477 4 May 20, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2024 2 $0 4 Mar 15, 2024 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Sep 20, 2023 1 -$924 4 Sep 21, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Aug 18, 2023 1 -$344 4 Aug 21, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jul 19, 2023 1 -$168 4 Jul 20, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jun 21, 2023 1 -$894 4 Jun 22, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. May 17, 2023 1 -$356 4 May 18, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Apr 19, 2023 1 -$147 4 Apr 20, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Mar 17, 2023 1 -$937 4 Mar 20, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2023 2 $0 4 Mar 15, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Mar 7, 2023 1 -$25.7K 4 Mar 8, 2023 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Oct 18, 2022 1 -$823 4 Oct 19, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Sep 19, 2022 1 -$1.76K 4 Sep 20, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Aug 31, 2022 1 $7.46K 4 Aug 31, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Aug 17, 2022 1 -$1.36K 4 Aug 18, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jul 19, 2022 1 -$2.84K 4 Jul 20, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jun 17, 2022 1 -$1.25K 4 Jun 21, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. May 17, 2022 1 -$1.17K 4 May 18, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2022 1 $0 4 Mar 16, 2022 Chief Commercial Officer
ESPR Esperion Therapeutics, Inc. Mar 1, 2022 0 $0 3 Mar 9, 2022 Chief Commercial Officer